The prevalence and predictor factors of urinary tract infection in type 2 diabetes mellitus patients receiving SGLT2 inhibitors in Qatar: A retrospective cohort study
{{output}}
Background and aims: Urinary Tract Infections (UTIs) are common in Type 2 Diabetes Mellitus (T2DM) patients. While Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitors improve T2DM treatment by lowering blood glucose, they may increase UTI risk. Research finding... ...
